Pulmonx
Latest round
- Series G
Last raised
- Apr 2019
Total raised
- $138M
Investors
- 13
About Pulmonx
Founded in 1998 and based in California, US, Pulmonx Corp. develops medical devices and technologies for the treatment of lung diseases. The company's products include Zephyr Valve, an invasive bronchoscopic treatment option that helps emphysema patients breathe easier; StratX, a cloud-based lung analysis platform that identifies the lobes for the Zephyr Valve treatment; and Chartis, a pulmonary assessment system.
Who invested in Pulmonx
13 investors across 6 rounds
See all investors in Pulmonx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pulmonx
Who invested in Pulmonx?
Pulmonx has 13 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pulmonx raised?
Pulmonx has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Pulmonx last raise money?
Pulmonx's most recent round on record is a Series G, in Apr 2019.
What does Pulmonx do?
Founded in 1998 and based in California, US, Pulmonx Corp.
Where is Pulmonx headquartered?
Pulmonx is headquartered in Redwood City, US.
Which VCs invest in companies like Pulmonx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Pulmonx's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series G
Raising like Pulmonx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.